Logo image of AL2SI.PA

2CRSI SA (AL2SI.PA) Stock Fundamental Analysis

EPA:AL2SI - Euronext Paris - Matif - FR0013341781 - Common Stock - Currency: EUR

6.83  +1.47 (+27.43%)

Fundamental Rating

3

Taking everything into account, AL2SI scores 3 out of 10 in our fundamental rating. AL2SI was compared to 30 industry peers in the Technology Hardware, Storage & Peripherals industry. AL2SI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. AL2SI is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

AL2SI had negative earnings in the past year.
In the past 5 years AL2SI always reported negative net income.
In multiple years AL2SI reported negative operating cash flow during the last 5 years.
AL2SI.PA Yearly Net Income VS EBIT VS OCF VS FCFAL2SI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -8.34%, AL2SI is doing worse than 80.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of -23.59%, AL2SI is doing worse than 66.67% of the companies in the same industry.
Industry RankSector Rank
ROA -8.34%
ROE -23.59%
ROIC N/A
ROA(3y)-6%
ROA(5y)-4.94%
ROE(3y)-24.19%
ROE(5y)-19.4%
ROIC(3y)N/A
ROIC(5y)N/A
AL2SI.PA Yearly ROA, ROE, ROICAL2SI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -10 -20 -30 -40

1.3 Margins

Looking at the Gross Margin, with a value of 95.25%, AL2SI belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of AL2SI has remained more or less at the same level.
AL2SI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 95.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.01%
GM growth 5YN/A
AL2SI.PA Yearly Profit, Operating, Gross MarginsAL2SI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

4

2. Health

2.1 Basic Checks

AL2SI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AL2SI has more shares outstanding
AL2SI has a better debt/assets ratio than last year.
AL2SI.PA Yearly Shares OutstandingAL2SI.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M 20M
AL2SI.PA Yearly Total Debt VS Total AssetsAL2SI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

AL2SI has an Altman-Z score of 4.07. This indicates that AL2SI is financially healthy and has little risk of bankruptcy at the moment.
AL2SI's Altman-Z score of 4.07 is fine compared to the rest of the industry. AL2SI outperforms 80.00% of its industry peers.
AL2SI has a Debt/Equity ratio of 0.39. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.39, AL2SI perfoms like the industry average, outperforming 56.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF N/A
Altman-Z 4.07
ROIC/WACCN/A
WACC7.19%
AL2SI.PA Yearly LT Debt VS Equity VS FCFAL2SI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

AL2SI has a Current Ratio of 1.69. This is a normal value and indicates that AL2SI is financially healthy and should not expect problems in meeting its short term obligations.
AL2SI's Current ratio of 1.69 is in line compared to the rest of the industry. AL2SI outperforms 56.67% of its industry peers.
A Quick Ratio of 1.08 indicates that AL2SI should not have too much problems paying its short term obligations.
AL2SI has a Quick ratio (1.08) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.69
Quick Ratio 1.08
AL2SI.PA Yearly Current Assets VS Current LiabilitesAL2SI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 64.98% over the past year.
Looking at the last year, AL2SI shows a decrease in Revenue. The Revenue has decreased by -2.51% in the last year.
The Revenue has been growing slightly by 3.08% on average over the past years.
EPS 1Y (TTM)64.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%192.84%
Revenue 1Y (TTM)-2.51%
Revenue growth 3Y3.08%
Revenue growth 5YN/A
Sales Q2Q%85.45%

3.2 Future

Based on estimates for the next years, AL2SI will show a very negative growth in Earnings Per Share. The EPS will decrease by -46.37% on average per year.
AL2SI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.16% yearly.
EPS Next Y1800%
EPS Next 2Y430.2%
EPS Next 3Y244.88%
EPS Next 5Y-46.37%
Revenue Next Year9.73%
Revenue Next 2Y20.47%
Revenue Next 3Y22.62%
Revenue Next 5Y14.16%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AL2SI.PA Yearly Revenue VS EstimatesAL2SI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M
AL2SI.PA Yearly EPS VS EstimatesAL2SI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2023 2024 2025 2026 2027 2028 0 0.5 1

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AL2SI. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 7.86, the valuation of AL2SI can be described as very cheap.
Based on the Price/Forward Earnings ratio, AL2SI is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 21.49. AL2SI is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 7.86
AL2SI.PA Price Earnings VS Forward Price EarningsAL2SI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

66.67% of the companies in the same industry are cheaper than AL2SI, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 64.01
AL2SI.PA Per share dataAL2SI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AL2SI's earnings are expected to grow with 244.88% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y430.2%
EPS Next 3Y244.88%

More info and screens

0

5. Dividend

5.1 Amount

AL2SI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

2CRSI SA

EPA:AL2SI (6/27/2025, 7:00:00 PM)

6.83

+1.47 (+27.43%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)04-01 2025-04-01/amc
Earnings (Next)N/A N/A
Inst Owners8.37%
Inst Owner ChangeN/A
Ins Owners50.96%
Ins Owner ChangeN/A
Market Cap152.38M
Analysts87.27
Price Target8.87 (29.87%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)12.99%
PT rev (3m)4.4%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.16%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-20.22%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.86
P/S 0.85
P/FCF N/A
P/OCF N/A
P/B 5.34
P/tB 6.69
EV/EBITDA 64.01
EPS(TTM)-0.3
EYN/A
EPS(NY)0.87
Fwd EY12.72%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS8.02
BVpS1.28
TBVpS1.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.34%
ROE -23.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 95.25%
FCFM N/A
ROA(3y)-6%
ROA(5y)-4.94%
ROE(3y)-24.19%
ROE(5y)-19.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.01%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover2.21
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF N/A
Debt/EBITDA 4.36
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.69
Quick Ratio 1.08
Altman-Z 4.07
F-ScoreN/A
WACC7.19%
ROIC/WACCN/A
Cap/Depr(3y)93.52%
Cap/Depr(5y)80.3%
Cap/Sales(3y)1.3%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%192.84%
EPS Next Y1800%
EPS Next 2Y430.2%
EPS Next 3Y244.88%
EPS Next 5Y-46.37%
Revenue 1Y (TTM)-2.51%
Revenue growth 3Y3.08%
Revenue growth 5YN/A
Sales Q2Q%85.45%
Revenue Next Year9.73%
Revenue Next 2Y20.47%
Revenue Next 3Y22.62%
Revenue Next 5Y14.16%
EBIT growth 1Y76.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year343.64%
EBIT Next 3Y95.54%
EBIT Next 5Y51.49%
FCF growth 1Y-158.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-126.1%
OCF growth 3YN/A
OCF growth 5YN/A